Mesa laboratories inc /co (MLAB)
CashFlow / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10
Net income

4,431

9,919

7,851

7,484

10,336

-1,608

-249

-2,962

-3,573

10,765

10,770

11,183

11,531

10,876

10,344

11,169

9,417

9,223

10,457

9,583

10,806

10,149

9,021

9,000

8,097

7,894

8,211

8,450

8,090

8,534

8,339

7,919

7,897

7,167

6,542

6,183

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

9,767

8,983

9,154

9,428

9,652

9,829

9,648

9,471

9,109

8,857

8,845

8,737

8,576

8,146

7,840

7,174

6,701

6,374

5,801

5,656

5,324

4,926

4,392

3,844

3,529

3,396

3,459

3,432

3,164

2,788

2,458

2,215

2,181

2,112

1,968

1,844

0

0

0

Stock-based compensation

7,098

4,533

4,341

4,212

2,673

2,416

1,871

1,672

1,613

1,555

1,522

1,411

1,547

1,511

1,429

1,327

1,218

1,134

1,041

993

987

999

970

840

844

1,031

1,112

1,112

1,012

710

517

464

445

413

413

383

0

0

0

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

28

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in inventory reserve

-149

377

250

380

-403

-2,486

-1,869

-2,474

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on dispositions, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-16

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred taxes

-

-

-

-

-

-

2,887

2,704

2,125

624

678

630

517

556

860

807

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency adjustments

-

-

-

-

-

-

-

490

145

412

150

-93

49

622

-99

-53

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustment to contingent consideration

-

-

-

-32

-32

-33

-192

300

0

0

300

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

-165

-184

-205

-45

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash provided by changes in operating assets and liabilities
Gain on loan settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Accounts receivable, net

-710

-1,195

825

-1,592

1,048

809

-1,094

-680

-1,246

-1,226

480

-994

-339

726

34

1,958

225

-329

419

2,291

2,499

2,638

2,308

-697

-323

-325

-709

1,510

1,052

320

125

-493

669

1,126

970

931

0

0

0

Inventories, net

-1,877

-1,847

-2,131

-2,574

-2,174

-2,348

-2,990

-2,286

-1,418

-1,409

7

-101

-491

1,307

1,123

1,507

1,725

2,197

2,784

3,164

3,956

2,340

1,617

1,300

979

421

515

228

-486

-272

-712

-1,276

-1,191

-1,194

-624

72

0

0

0

Prepaid expenses and other assets

697

4,105

4,137

2,898

2,169

-1,695

-1,126

-755

1,423

2,562

2,115

830

743

-491

-349

-391

-274

-845

-594

-772

516

1,563

1,364

1,479

728

921

615

189

-18

-5

-42

-38

17

7

3

-180

0

0

0

Accounts payable

845

591

648

1,092

662

274

536

212

-890

-1,448

-419

-655

-134

446

-38

-150

-257

-157

267

410

1,396

1,052

108

754

232

668

636

437

279

75

207

-150

110

14

99

-1

0

0

0

Accrued liabilities and taxes payable

-2,294

958

2,731

5,477

5,534

1,361

629

408

-416

507

-1,229

-3,066

-1,487

-4,789

-48

2,865

529

1,708

-873

-861

-961

1,270

2,423

1,192

1,685

842

-1,911

189

-58

654

758

142

22

46

924

1,696

0

0

0

Unearned revenues

460

245

264

54

67

-61

-203

-196

-186

-501

-352

-228

-267

-54

238

99

-225

168

-199

-572

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

28,418

27,492

24,735

30,554

29,933

28,551

29,581

25,719

26,611

23,343

16,353

17,304

13,721

9,270

17,674

16,903

14,593

16,034

13,251

10,816

9,075

10,538

9,994

12,373

12,425

12,055

10,795

11,402

12,031

12,810

13,013

12,489

10,746

9,399

9,170

8,868

0

0

0

Cash flows from investing activities:
Acquisitions

0

0

0

-

-

-

-

15,518

15,615

3,461

4,297

6,800

7,530

6,825

26,676

24,111

24,692

27,413

6,726

20,543

0

0

0

-

-

-

-

16,660

0

0

0

-

-

-

-

17,973

0

0

0

Deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Capital expenditures, building

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Purchases of property, plant and equipment

-

-

1,188

-

-

-

1,594

2,799

4,778

6,948

9,654

11,605

10,805

9,363

9,510

7,729

6,907

6,955

4,110

2,828

2,445

1,178

1,019

1,041

1,060

1,309

1,138

908

794

710

681

683

2,762

2,678

2,636

2,645

0

0

0

Net cash (used in) investing activities

-185,092

-8,351

-6,361

-3,880

-4,169

-14,870

-15,917

-17,184

-19,260

-9,276

-13,951

-18,405

-18,335

-16,188

-36,186

-31,840

-31,599

-34,368

-10,836

-23,371

-21,495

-36,032

-36,933

-23,138

-23,157

-2,369

-1,138

-17,568

-17,479

-18,107

-18,078

-1,420

-1,324

-6,762

-6,425

-20,618

0

0

0

Cash flows from financing activities:
Proceeds from the issuance of debt

-

-

-

-

-

-

-

-

-

-

-

66,550

11,500

12,000

26,500

25,000

25,000

27,500

5,000

23,000

0

0

0

-

-

-

-

11,000

0

0

0

-

-

-

-

7,000

0

0

0

Payments on debt

29,500

35,375

21,750

25,625

29,000

25,875

22,250

19,625

63,000

62,000

60,500

57,000

5,500

6,000

5,500

6,000

6,000

6,500

8,000

13,250

14,000

13,250

12,500

8,500

0

0

0

-

-

-

-

6,500

0

0

0

-

-

-

-

Dividends

2,638

2,557

2,476

2,462

2,449

2,438

2,422

2,413

2,402

2,387

2,373

2,355

2,339

2,328

2,317

2,303

2,288

2,274

2,225

2,182

2,140

2,089

2,041

1,989

1,941

1,896

1,855

1,815

1,770

1,728

1,685

1,645

1,607

1,567

1,531

1,488

0

0

0

Contingent Consideration

-

-

-

-680

-677

-1,132

-931

-905

-5,383

-5,416

-10,102

-9,554

-5,364

-4,451

-827

-2,058

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the exercise of stock options

5,355

5,426

4,761

5,095

4,161

4,031

4,999

2,919

3,044

3,810

3,316

3,513

2,938

2,844

2,523

1,923

2,167

1,485

1,629

1,504

1,915

2,073

2,098

1,845

1,171

922

768

898

1,593

1,419

1,152

1,318

578

632

645

196

0

0

0

Net cash provided by (used in) financing activities

225,268

220,879

-18,145

-21,672

-25,965

-18,187

-9,578

-9,024

-6,767

-9,081

-4,061

1,154

6,599

6,516

21,206

18,620

18,879

20,211

-3,596

9,072

11,768

25,727

26,550

12,334

10,170

-9,034

-10,661

2,981

2,479

3,117

3,604

-7,424

-5,860

-1,260

768

4,825

0

0

0

Purchase and retirement of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

60

60

74

102

594

574

613

597

81

104

125

105

0

0

0

Effect of exchange rate changes on cash and cash equivalents

-344

-202

-314

-286

87

-137

338

138

-146

212

-2

72

148

12

-25

-22

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

68,250

239,818

-85

4,716

-114

-4,643

4,424

-351

438

5,198

-1,661

125

2,133

-390

2,669

3,661

1,845

1,803

-1,232

-3,541

-733

233

-389

1,569

-562

652

-1,004

-3,185

-2,969

-2,180

-1,461

3,645

3,562

1,377

3,513

-6,925

0

0

0

Income taxes

-

0

7,313

-

-

7,415

4,177

4,551

5,608

4,911

5,056

5,605

4,764

4,229

4,814

3,951

3,931

4,715

3,415

3,345

4,255

3,016

2,553

4,714

3,901

5,154

6,805

4,778

5,302

5,137

4,815

4,457

0

0

0

-

-

-

-

Interest

-

0

1,398

-

-

1,887

1,851

1,956

1,948

1,803

1,653

1,384

1,198

1,121

1,011

848

708

604

536

499

0

0

0

-

-

-

0

-

-

-

-

176

184

197

177

141

0

0

0

Contingent consideration as part of an acquisition

-

-

0

-

-

-

-

-

-

-

-

-

1,552

1,552

10,439

9,271

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Employee loans issued for exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

203

338

327

331

396

278

365

350

437

0

0

0

Repayment of employee loans for stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

24

24

24

92

195

195

253

450

483

480

422

437

0

0

0

-

-

-

-